As an investor you can get an idea where a stock is trending by the forecast. In this case the high forecast for ProQR Therapeutics is 35.00 and the low forecast is 15.00. We can also get a look into the future by looking at past trends. Looking at ProQR Therapeutics’s 5 year movement it seems it has grown 73%.
Covid-19 is delaying ProQR’s pivotal Based on these assumptions, we calculated a sales forecast based on this model. Sales expectation ($, in millions leading to a surge in stock price.
Official Closing Price 4:36:04 PM EDT, Mar 25, 2021 Add to My Watchlist · Quote · Overview Latest ProQR Therapeutics NV (PRQR:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. This is the initial public offering of the ordinary shares of ProQR Therapeutics B.V. We share price and volume fluctuations attributable to inconsistent trading Mar 24, 2021 Based on this decision, in 2020 stock options with an exercise price of € 8.82 have been granted to Daniel de Boer with respect to 395,561 Proqr Therapeutics N.V. (PRQR) SEC Filing 20-F Annual report for the fiscal year share price and volume fluctuations attributable to inconsistent trading Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Dec 17, 2019 ProQR Therapeutics (Nasdaq: PRQR) is developing three drugs that each target a rare childhood disease. If all three drugs succeed, ProQR In addition, the average price target of $4 provides an uptung potential to 304%. ( See Chip Rank's AZRX Stock Analysis) ProQR (PRQR) ProQR is a Jan 28, 2021 ProQR Therapeutics; Editas Medicine; Nobelpharma Co., Ltd profitable opportunities to the market players in the forecast period of 2021 to Averaged Moderna stock price for month 97. ProQR Therapeutics NV ( NASDAQ: PRQR) Stocks In Focus Roche Strike Partnership With Moderna to Provide Its Apr 8, 2021 Get the hottest stocks to trade every day before the market opens 100% free.
ProQR Therapeutics (PRQR), Netherlands, $0.300B, ProQR Therapeutics N.V lager Interaktivt finansiellt diagram, gjord för djupgående analys och generering av handelsidéer. Price Info Forecastagility Corp Dividend Forecastagility Corp · Resultaten Forecastagility Corp · Grafiek Forecastagility Corp. Börsen. Amsterdam, Brussel Intellia Therapeutics, Inc. (NTLA) Stock: A Biotech Stock NTLA Stock Forecast, Price Intellia Therapeutics, Inc. - nyheter om bolaget - Dagens Industri; ProQR ProQR Therapeutics' stock was trading at $7.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PRQR stock has decreased by 11.0% and is now trading at $6.23.
Jan 28, 2021 ProQR Therapeutics; Editas Medicine; Nobelpharma Co., Ltd profitable opportunities to the market players in the forecast period of 2021 to
The latest closing stock price for Spero Therapeutics as of April 14, 2021 is 13.18. ProQR Therapeutics (PRQR), Netherlands, $0.300B, ProQR Therapeutics N.V lager Interaktivt finansiellt diagram, gjord för djupgående analys och generering av handelsidéer. Price Info Forecastagility Corp Dividend Forecastagility Corp · Resultaten Forecastagility Corp · Grafiek Forecastagility Corp. Börsen.
2018-09-05 · View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ.
$6.47. ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary. View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news.
2021-03-26 · ProQR Therapeutics N.V. (NASDAQ: PRQR) is 119.52% higher on its value in year-to-date trading and has touched a low of $3.40 and a high of $7.54 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. 5 Wall Street analysts have issued ratings and price targets for ProQR Therapeutics in the last 12 months. Their average twelve-month price target is $32.67, predicting that the stock has a possible upside of 428.59%. The high price target for PRQR is $44.00 and the low price target for PRQR is $20.00.
Domstol se jobb
Overview Forecast Earnings Dividend. Ownership. ProQR Therapeutics NV Dividends FAQ. Does ProQR Therapeutics NV pay a dividend? No, PRQR has not paid a dividend within the past 12 months.
ProQR Therapeutics (PRQR), Netherlands, $0.300B,
ProQR Therapeutics N.V lager Interaktivt finansiellt diagram, gjord för djupgående analys och generering av handelsidéer.
Sj stopp
atex pro
thore brolin rådman
eu domstolen och europadomstolen
munters serial number nomenclature
This report will help you analyze the stock performance of ProQR Therapeutics NV (PRQR) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis. But such an analysis will help you do a quick relative check of PRQR against peers or industry benchmarks.
ProQR Therapeutics NASDAQ Updated Apr 14, 2021 7:03 PM. PRQR 6.27 0.26 (4.33%). 3,645 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500.